Yakult Honsha Co.,Ltd. Stock

Equities

2267

JP3931600005

Food Processing

Market Closed - Japan Exchange 02:00:00 2024-04-26 EDT 5-day change 1st Jan Change
3,058 JPY -0.62% Intraday chart for Yakult Honsha Co.,Ltd. +2.67% -3.44%

Financials

Sales 2024 * 506B 3.2B 4.37B Sales 2025 * 519B 3.28B 4.48B Capitalization 937B 5.91B 8.08B
Net income 2024 * 50.94B 322M 440M Net income 2025 * 52.76B 333M 455M EV / Sales 2024 * 1.53 x
Net cash position 2024 * 162B 1.02B 1.4B Net cash position 2025 * 183B 1.15B 1.58B EV / Sales 2025 * 1.45 x
P/E ratio 2024 *
18.5 x
P/E ratio 2025 *
17.7 x
Employees 29,880
Yield 2024 *
1.8%
Yield 2025 *
1.87%
Free-Float 71.96%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.62%
1 week+2.67%
Current month-1.96%
1 month-2.30%
3 months-4.76%
6 months-14.00%
Current year-3.44%
More quotes
1 week
3 023.00
Extreme 3023
3 115.00
1 month
2 920.50
Extreme 2920.5
3 152.00
Current year
2 920.50
Extreme 2920.5
3 334.00
1 year
2 920.50
Extreme 2920.5
5 215.00
3 years
2 645.00
Extreme 2645
5 215.00
5 years
2 407.50
Extreme 2407.5
5 215.00
10 years
2 252.50
Extreme 2252.5
5 215.00
More quotes
Managers TitleAgeSince
President 72 74-03-31
Chief Administrative Officer 72 77-03-31
Director/Board Member - -
Members of the board TitleAgeSince
Director/Board Member 78 09-05-31
Chief Administrative Officer 72 77-03-31
President 72 74-03-31
More insiders
Date Price Change Volume
24-04-26 3,058 -0.62% 1,127,500
24-04-25 3,077 -0.23% 762,200
24-04-24 3,084 -0.55% 1,066,000
24-04-23 3,101 0.00% 1,159,600
24-04-22 3,101 +4.11% 1,989,400

Delayed Quote Japan Exchange, April 26, 2024 at 02:00 am

More quotes
YAKULT HONSHA CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of dairy products and pharmaceuticals. The Company operates in three business segments. The Beverages and Food Manufacturing and Sale segment is engaged in the manufacture and sale of dairy products, beverages, noodles and healthy food, the purchase and sale of materials, as well as the transportation business. The Company operates business in Japan, the Americas, Europe, Asia and Oceania. The Pharmaceuticals Manufacturing and Sale segment is engaged in the manufacture and sale of anticancer drugs and other ethical drugs. The Others segment is engaged in the production and sale of cosmetics, as well as the operation of professional baseball clubs.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
10
Last Close Price
3,058 JPY
Average target price
3,529 JPY
Spread / Average Target
+15.40%
Consensus